Delivery Order SPE2DB25D3504-SPE2DB25FVWAM
- Not listed
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- This delivery order, valued at $3,143.94, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vevye 0.1% eye drops in 2ML units to support federal medical procurement needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA). The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25,...
- This delivery order, issued on July 30, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $4,203.19 to supply VEVYE 0.1% Eye Drop (2mL) to the Defense Logistics Agency (DLA). The contract is categorized as a child contract under a larger vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This award was competitively awarded with no set-aside designation,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,211.41 firm fixed-price delivery order is for VEVYE 0.1% eye drops, 2ml, with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.16 fixed-price delivery order is for the supply of a specific pharmaceutical product, VEVYE 0.1% eye drops, with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWAMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,664.95 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution in 2ML units. This firm fixed price delivery order, awarded on August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside provisions and was competitively awarded. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. Through the SPE2DX prime contract vehicle, the company supplies a comprehensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers worldwide. This delivery order for ophthalmic medication exemplifies the routine pharmaceutical supply deliveries executed under this expansive global pharmaceutical support contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/19/25 |